1. Johnson & Johnson

    0 Comments Leave a Comment

    1-15 of 62 1 2 3 4 »
    1. Mentioned In 62 Articles

    2. Johnson & Johnson Names Dr. Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General to its Board of Directors

      Johnson & Johnson Names Dr. Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General to its Board of Directors
      NEW BRUNSWICK, N.J.,Dec. 3, 2020/PRNewswire/ -- Johnson Johnson (NYSE:JNJ)announced today that Dr.Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General has been appointed to its Board of Directors...
      Read Full Article
    3. Question of The Week -- October 29, 2020

      Question of The Week -- October 29, 2020
      As outlined this past week by The Boston Globe, executives and board members at pharmaceutical companies involved in the development of Covid-19 vaccines have been amassing small fortunes during the past few months through the sale of stock they own in those companies -- benefiting from public speculation on the efficacy of such vaccines. Although legally, on its face, there is nothing wrong with such sales, is it time for the ...
      Read Full Article
    4. 1-15 of 62 1 2 3 4 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes about Johnson & Johnson

    1. Rob's experience and record of success at Epizyme, Synageva, Johnson & Johnson and Merck position him as an invaluable addition for Ardelyx, and we are excited that he will be joining our Board.
      In Ardelyx Appoints Robert Bazemore to Its Board of Directors
    2. In a statement Thursday, Johnson & Johnson said it .
      In J&J, shareholders reach tentative deal in lawsuit
    3. This vote demonstrates the significant disapproval among Johnson & Johnson shareholders.
      In J&J Execs Get Pay Raises, But Only After Bruising Shareholder 'Vote No' Campaign